Table 2.
Factors associated with prognosis in patients with anti-NMDAR encephalitis.
| Variables | PRC | P values | OR values | 95% CI | |
|---|---|---|---|---|---|
| Lower | Upper | ||||
| Binary logistic regression analysis | |||||
| Consciousness disturbance | 1.591 | 0.004 | 4.907 | 1.653 | 14.562 |
| EEG BA | 1.32 | 0.001 | 3.743 | 1.766 | 7.932 |
| Number of symptoms | 1.068 | 0.000 | 2.911 | 1.811 | 4.679 |
| CSF antibody titers | 3.459 | 0.000 | 31.778 | 8.891 | 113.57 |
| Variables | Area (%) | P values | Sensitivity (%) | Specificity (%) |
|---|---|---|---|---|
| ROC curve | ||||
| Consciousness disturbance | 65.4% | 0.014 | 44.2 | 86.5 |
| EEG BA | 76.6% | 0.000 | 73 | 75 |
| Number of symptoms | 77.1% | 0.000 | 59.5 | 78.6 |
| CSF antibody titers | 83.9% | 0.000 | 89.2 | 78.6 |
EEG BA EEG background activity during peak stage, PRC partial regression coefficient.